Will uniQure's AMT-130 receive FDA Accelerated Approval by end of 2025? | Binary | | | 13 days ago | |
Will uniQure submit BLA for AMT-130 to FDA by mid-2025? | Binary | | | 13 days ago | |
Will Sangamo submit BLA for ST-920 by end of 2025? | Binary | | | 2 months ago | |
Will AMT-130 show significant improvement in cUHDRS by end of 2024? | Binary | | | 13 days ago | |
What will be the outcome of AMT-130 Phase I/II trials by Q1 2025? | Categorical | | | 13 days ago | |
How will uniQure's stock price change after FDA decision on AMT-130? | Categorical | | | 13 days ago | |
What will be the next major regulatory milestone for AMT-130 by end of 2025? | Categorical | | | 13 days ago | |
What will be the outcome of Sangamo's BLA for ST-920 by end of 2026? | Categorical | | | 2 months ago | |
Will FDA grant Accelerated Approval to ST-920 by end of 2026? | Binary | | | 2 months ago | |
How many competitors will enter Fabry gene therapy market by end of 2025? | Categorical | | | 2 months ago | |
How will Sangamo's stock react within a week of FDA's ST-920 decision? | Categorical | | | 2 months ago | |
Will Sangamo announce positive Phase 3 results for ST-920 by end of 2025? | Binary | | | 2 months ago | |
